Possible targets for a multiple myeloma vaccine

Joint research conducted by the Weill Medical College of Cornell University and the Ludwig Institute for Cancer Research in New York has identified two proteins, CT7 and MAGE-A3/6, in human myeloma cells responsible for multiple myeloma, a blood cancer. The researchers believe these proteins may be ideal targets for a multiple myeloma vaccine. Studies are underway to see if immune cells of people with the disease can recognize and attack cells that have either CT7 or MAGE-A3/6. The protein research was published in the March 2005 online edition of Blood.